Genetic Technologies Named Tony Di Pietro as CFO

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce the appointment of experienced Chief Financial Officer, Mr Tony Di Pietro. Tony will also be appointed as Company Secretary upon his arrival. Mr Di Pietro is a Chartered Accountant and an Associate of the Governance Institute Australia with 18 years Biotechnology industry experience.